Talphera (TLPH) Other Non-Current Assets (2010 - 2022)
Talphera's (TLPH) quarterly Other Non-Current Assets came in at $1.9 million in Q4 2022, down 61.38% year-on-year from $5.0 million in Q4 2021, and up 669.32% quarter-over-quarter from $251000.0 in Q3 2022.
Talphera (TLPH) Other Non-Current Assets (2010 - 2022) Analysis & Trends
Talphera's Other Non-Current Assets history runs 13 years deep, the most recent figure standing at $1.9 million for Q4 2022.
- On a quarterly basis, Other Non-Current Assets fell 61.38% year-over-year to $1.9 million in Q4 2022; TTM through Dec 2022 was $1.9 million, a 61.38% decrease from a year earlier, with the FY2022 full-year figure at $1.9 million, down 61.38% from the prior year.
- Other Non-Current Assets improved to $1.9 million in Q4 2022 per TLPH's latest filing, from $251000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $5.0 million in Q4 2020 and bottomed at $70000.0 in Q1 2021.
- The 5-year median for Other Non-Current Assets is $900000.0 (2019), against an average of $1.6 million.
- Across the five-year window, Other Non-Current Assets soared 594.44% in 2021 and slumped 94.98% in 2022, its largest moves.
- Year by year, Other Non-Current Assets stood at $705000.0 in 2018, then soared by 68.51% to $1.2 million in 2019, then jumped by 320.88% to $5.0 million in 2020, then changed by 0.0% to $5.0 million in 2021, then slumped by 61.38% to $1.9 million in 2022.
- Per Business Quant, the three latest TLPH Other Non-Current Assets figures stand at $1.9 million (Q4 2022), $251000.0 (Q3 2022), and $261000.0 (Q1 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.93 Mn |
| Sep 30, 2022 | 251,000.00 |
| Mar 31, 2022 | 261,000.00 |
| Dec 31, 2021 | 5.00 Mn |
| Sep 30, 2021 | 5.00 Mn |
| Jun 30, 2021 | 5.00 Mn |
| Mar 31, 2021 | 70,000.00 |
| Dec 31, 2020 | 5.00 Mn |
| Sep 30, 2020 | 720,000.00 |
| Jun 30, 2020 | 784,000.00 |
| Mar 31, 2020 | 902,000.00 |
| Dec 31, 2019 | 1.19 Mn |
| Sep 30, 2019 | 984,000.00 |
| Jun 30, 2019 | 1.02 Mn |
| Mar 31, 2019 | 900,000.00 |
| Dec 31, 2018 | 705,000.00 |
| Sep 30, 2018 | 178,000.00 |
| Jun 30, 2018 | 178,000.00 |
| Mar 31, 2018 | 178,000.00 |
| Dec 31, 2017 | 207,000.00 |